Lipid Lowering Agents | Pharmaceuticals & Biotechnology > Pharmaceutical Agents & Products | Business solutions from AllBusiness.com
Facebook Twitter You Tube RSS Feed
Related

Journals By Industry - Lipid Lowering Agents

Choose your industry from the list to the left.

Today's Must Read
Publication: LexisNexis | Filed In: Kidney Disease and Urogenital Disorders
In SHARP, VYTORIN 10/20 mg lowered LDL cholesterol in patients with moderate to severe chronic kidney disease, or CKD, and major vascular events were reduced in the treatment group compared to placebo. The...
Business Journal
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/a40950/market_and_product) has announced the addition of the "Market and Product Forecasts: Antidyslipidemics - Set for the impact of generic Lipitor" report to their offering. The industry is bracing...
Press Release
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/2458e4/myocardial_infarct) has announced the addition of GlobalData 's new report "Myocardial Infarction (MI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. GlobalData, the industry...
Press Release
Publication: LexisNexis | Filed In: Arthritis and Musculoskeletal Diseases
Not had time to read the journals? Let Dr Louise Newson bring you up to date on the latest research. - Bisphosphonates may be beneficial before knee and hip replacements BMJ 2011; 343:...
Business Journal
Publication: LexisNexis | Filed In: Cholesterol and Diet, Nutrition & Fitness
The Phase III study was a single-arm, open label trial, designed to evaluate the efficacy and long-term safety of lomitapide for the treatment of patients with homozygous familial hypercholesterolemia, or HoFH. The data...
Business Journal
By Quigley, Kelly | Publication: San Diego Business Journal | Filed In: Sales Figures and Sales & Selling
While many San Diego companies were taking it slow in the weeks leading up to 2012, Carmel Valley-based biopharmaceutical firm Santarus Inc. was taking action on plans to expand its product portfolio. The...
Business Journal
ALN-PCS demonstrated statistically significant RNAi silencing of PCSK9 of up to 66% and reductions of up to over 50% in levels of low-density lipoprotein cholesterol, or LDL-C, or bad cholesterol, a clinically validated...
Business Journal
Publication: Business Wire | Filed In: Medical Research and Medical Science
- RNAi Therapeutic Achieves Robust Silencing of PCKS9 and Reductions of Over 50% in LDL Cholesterol, a Validated Clinical Endpoint - - Results Highlight Major Potency Improvements of Second-Generation Lipid Nanoparticle Platform in...
Press Release
By Arnold, Matthew | Publication: Medical Marketing and Media | Filed In: Lipid Lowering Agents and Cardiovascular Drugs
Out of 240 branded pharma websites, only about a fifth have any African American imagery on their pages, and bilingual sections of pharma sites are often missing important elements like the "Questions to...
Business Journal
By Iskowitz, Marc | Publication: Medical Marketing and Media | Filed In: Generic Products and Product Management
Copycat versions of Pfizer's Lipitor could capture more than half the market for the cholesterol-lowering drug while taking share from other statins, analysts predict. Generic atorvastatin made its debut Nov. 30, and analysts...
Business Journal
Company Profiles Leading Local Companies Strengths The world's largest drugmakers in terms of revenue. A focus on R&D to drive growth. Weaknesses Loss of patent protection for Lipitor (atorvastatin) in the US during...
Business Journal
Strengths One of the leading foreign pharmaceutical companies in Serbia. Extensive range of prescription medicines, as well as OTCs and animal health products. Long history of involvement in the Serbian market. Weaknesses Strong...
Business Journal
Strengths...
Business Journal
Multinational Companies...
Business Journal
Company Monitor Indigenous Companies Strengths Strong position in its core markets of the Czech Republic and Slovakia, with growth targeted in Romania. The acquisition of Sicomed in Romania in late 2005 provided a...
Business Journal
Strengths One of the leading regional players. Krka's leading market is South East Europe, which covers Croatia. Strong generic medicines portfolio. Considerable local market knowledge and experience and direct manufacturing presence. Weaknesses Downward...
Business Journal
Multinational Companies Overview Pfizer is the leading pharmaceutical company in Thailand, a position attained following the acquisition of Pharmacia, and strengthened with the 2009 take-over of Wyeth. The company provides sales, marketing, medical,...
Business Journal
Publication: LexisNexis | Filed In: Antibiotics and Anti-Infectives
Company Monitor Local Manufacturers SWOT Analysis Strengths Significant product portfolio, with an estimated 6.5% market share in 2008.Solid presence in distribution ensures high margins and efficiency.The acquisition of BMS's local plant in Argentina...
Business Journal
SWOT Analysis Strengths Strong international presence based on its diversified regional presence, with manufacturing facilities in Chile and a subsidiary in Mexico.Bagó holds local co-marketing arrangements with leading research-based foreign players.As an Argentine...
Business Journal
SWOT Analysis Strengths...
Business Journal

TRENDING NOW:   Save. Spend. Do.,  Free Downloads!,  Credit Crunch Plagues Small Businesses,  Business Resource Center,
BootCamps